A Winning Strategy For Grant Applications: Focus On Impact

Sidebar: The Dos and Don'ts of Winning Dollars Sidebar: Grant Writing - For More Information A NEW STRATEGY: UC-Irvine’s Keith Woerpel, who revised his rejected grant applications to focus on impact, now has several grants. To Keith Woerpel, 1994 will forever be the year he learned to write grants-the hard way. An assistant professor of chemistry at the University of California, Irvine, Woerpel wrote five grant applications that year. All were rejected. "I was getting burned really badly

Written byKathryn Brown
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Sidebar: The Dos and Don'ts of Winning Dollars
Sidebar: Grant Writing - For More Information

"I was getting burned really badly," Woerpel remembers. Obviously, something was wrong. When Woerpel shared research ideas with colleagues, he sounded animated. But that animation didn't come through when he was writing up his work for grant reviewers. Reading his grant applications was like perusing term papers. "If I'd been writing a 10-page paper for college, I would have been very proud," he says.

Painful as it was, Woerpel forced himself to go over his rejected grants, paragraph by paragraph. Then he did some reorganizing. His goal: to sound less like a student, and more like a researcher brainstorming with friends. Instead of rambling into a grant application with a long research history, he started with a quick bit of context-and then explained how his work added to it. The new focus, he says, was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies